AURSOS

About:

Aursos is a biotechnology company.

Top Investors: Ann Arbor SPARK

Description:

Aursos, Inc., a biotechnology company, develops drugs for the treatment of bone loss. It develops black bear PTH (BB-PTH) 1-34 for the prevention and treatment of osteoporosis, as well as for patients suffering from disuse osteoporosis due to chronic immobilization. The company was founded in 2007 and is based in Kalamazoo, Michigan with an additional office in Houghton, Michigan.

Total Funding Amount:

$2.84M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Kalamazoo, Michigan, United States

Founded Date:

2007-01-01

Founders:

Ronald Shebuski

Number of Employees:

1-10

Last Funding Date:

2013-10-11

IPO Status:

Private

Industries: